Further, obesity was associated with hyperinsulinemia and caused abnormalities in the insulin signaling pathway (5), which may impact the expression and localization of insulin-related factors, such as InsR, in breast cancer. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.